Drug × Cancer matrix

Drugs that target a gene either directly (oncogene) or via a synthetic-lethal partner (SLP) of a mutated tumour suppressor (TSG). Cell colour shows the strongest known status of that drug for that cancer subtype: approved clinical trial repositionable (potential reuse, no evidence yet) or blank.

Cancer key
GBM — Glioblastoma (CNS astrocytoma grade IV) LUAD — Lung adenocarcinoma SCLC — Small cell lung carcinoma LUSC — Lung squamous cell carcinoma OAC — Oesophageal adenocarcinoma OSCC — Oesophageal squamous cell carcinoma PDAC — Pancreatic ductal adenocarcinoma
Relationship
Show
Clear
Showing 200 of 560 drug-target rows in SSL view, for TSG = KEAP1.
Drug TSG SLP (drug target) GBM LUAD SCLC LUSC OAC OSCC PDAC #
docetaxel, thalidomide KEAP1 BCL2 4
neo212 oral capsule, ipilimumab, pembrolizumab, nivolumab, regorafenib, carboplatin, paclitaxel, folfiri protocol, bevacizumab KEAP1 BCL2 4
adavosertib, afatinib, afatinib dimaleate, binimetinib, biopsy, biospecimen collection, capivasertib, computed tomography, copanlisib, copanlisib hydrochloride, crizotinib, cytology specimen collection procedure, dabrafenib, dabrafenib mesylate, dasatinib, defactinib, defactinib hydrochloride, echocardiography, erdafitinib, fexagratinib, ipatasertib, laboratory biomarker analysis, larotrectinib, larotrectinib sulfate, magnetic resonance imaging, multigated acquisition scan, nivolumab, osimertinib, palbociclib, pertuzumab, pi3k-beta inhibitor gsk2636771, radiologic examination, radionuclide imaging, relatlimab, sapanisertib, sunitinib malate, taselisib, trametinib, trastuzumab, trastuzumab emtansine, ulixertinib, vismodegib KEAP1 PIK3CB 3
adavosertib, afatinib, afatinib dimaleate, binimetinib, biopsy, biospecimen collection, capivasertib, computed tomography, copanlisib, copanlisib hydrochloride, crizotinib, cytology specimen collection procedure, dabrafenib, dabrafenib mesylate, dasatinib, defactinib, defactinib hydrochloride, echocardiography, erdafitinib, fexagratinib, ipatasertib, laboratory biomarker analysis, larotrectinib, larotrectinib sulfate, magnetic resonance imaging, multigated acquisition scan, nivolumab, osimertinib, palbociclib, pertuzumab, pi3k-beta inhibitor gsk2636771, radiologic examination, radionuclide imaging, relatlimab, sapanisertib, sunitinib malate, taselisib, trametinib, trastuzumab, trastuzumab emtansine, ulixertinib, vismodegib KEAP1 PIK3CA 3
adavosertib, afatinib, afatinib dimaleate, binimetinib, biopsy, biospecimen collection, capivasertib, computed tomography, copanlisib, copanlisib hydrochloride, crizotinib, cytology specimen collection procedure, dabrafenib, dabrafenib mesylate, dasatinib, defactinib, defactinib hydrochloride, echocardiography, erdafitinib, fexagratinib, ipatasertib, laboratory biomarker analysis, larotrectinib, larotrectinib sulfate, magnetic resonance imaging, multigated acquisition scan, nivolumab, osimertinib, palbociclib, pertuzumab, pi3k-beta inhibitor gsk2636771, radiologic examination, radionuclide imaging, relatlimab, sapanisertib, sunitinib malate, taselisib, trametinib, trastuzumab, trastuzumab emtansine, ulixertinib, vismodegib KEAP1 MAPK14 3
amg 193, docetaxel, comparator amg 193 test tablet KEAP1 BCL2 3
bms-986340, bms-936558-01, docetaxel KEAP1 BCL2 3
alectinib, brigatinib, lorlatinib 100 mg, osimertinib, sotorasib, dabrafenib, trametinib, selpercatinib, pembrolizumab, cemiplimab, nivolumab, carboplatin, pemetrexed, paclitaxel KEAP1 BCL2 2
alvocidib, paclitaxel KEAP1 BCL2 2
asp2138, pembrolizumab, oxaliplatin, leucovorin, fluorouracil, ramucirumab, paclitaxel, irinotecan KEAP1 BCL2 2
bevacizumab, dasatinib, fluorouracil, leucovorin, leucovorin calcium, oxaliplatin, quality-of-life assessment KEAP1 MAPK14 2
bryostatin 1, paclitaxel KEAP1 BCL2 2
btla inhibitor (js004), toripalimab, paclitaxel, cisplatin KEAP1 BCL2 2
capecitabine, docetaxel KEAP1 BCL2 2
carboplatin, celecoxib, paclitaxel, adjuvant therapy, conventional surgery, neoadjuvant therapy KEAP1 BCL2 2
carboplatin, docetaxel KEAP1 BCL2 2
carboplatin, endoscopic biopsy, external beam radiation therapy, lenvatinib mesylate, paclitaxel, pembrolizumab, resection KEAP1 BCL2 2
carboplatin, esophagectomy, intensity-modulated radiation therapy, paclitaxel, proton beam radiation therapy, quality-of-life assessment, questionnaire administration, folfox regimen, capox regimen, docetaxel, 5fu KEAP1 BCL2 2
carboplatin, fluorouracil, paclitaxel, conventional surgery, radiation therapy KEAP1 BCL2 2
carboplatin, paclitaxel, panitumumab, radiotherapy KEAP1 BCL2 2
carboplatin, paclitaxel, radiation therapy, telomerase-specific type 5 adenovirus obp-301 KEAP1 BCL2 2
carboplatin, paclitaxel, three-dimensional conformal radiation therapy KEAP1 BCL2 2
cetuximab, cisplatin, docetaxel, adjuvant therapy, neoadjuvant therapy KEAP1 BCL2 2
chemotherapy, cisplatin, paclitaxel, low-let electron therapy, low-let photon therapy KEAP1 BCL2 2
cisplatin, docetaxel, irinotecan hydrochloride, radiation therapy KEAP1 BCL2 2
cisplatin, fluorouracil, paclitaxel, conventional surgery, neoadjuvant therapy, radiation therapy KEAP1 BCL2 2
cisplatin, fluorouracil, paclitaxel, surgical procedure, radiation therapy KEAP1 BCL2 2
cisplatin, paclitaxel, surgical procedure, radiation therapy KEAP1 BCL2 2
cixutumumab, laboratory biomarker analysis, paclitaxel, pharmacological study KEAP1 BCL2 2
dkn-01 150 mg, paclitaxel, pembrolizumab, dkn-01 300 mg KEAP1 BCL2 2
docetaxel, 5-fu, radiotherapy, esophagectomy, dexamethasone KEAP1 BCL2 2
durvalumab, tremelimumab, oxaliplatin, capecitabine, radiotherapy, paclitaxel, carboplatin, 5-fluorouracil (5-fu), leucovorin, docetaxel KEAP1 BCL2 2
filgrastim, cisplatin, fluorouracil, paclitaxel, radiation therapy KEAP1 BCL2 2
filgrastim, paclitaxel, topotecan hydrochloride KEAP1 BCL2 2
filgrastim, pegfilgrastim, cisplatin, fluorouracil, paclitaxel, conventional surgery, radiation therapy KEAP1 BCL2 2
gemcitabine hydrochloride, paclitaxel, tipifarnib, radiation therapy KEAP1 BCL2 2
irinotecan, docetaxel KEAP1 BCL2 2
melphalan, bcnu, vitamin b12b, vitamin c, ethanol, autologous hematopoietic stem cells KEAP1 CACNG1 2
melphalan, bcnu, vitamin b12b, vitamin c, ethanol, autologous hematopoietic stem cells KEAP1 CHRNA9 2
mk-0482, pembrolizumab, paclitaxel, nab-paclitaxel, gemcitabine, carboplatin, pemetrexed KEAP1 BCL2 2
mk-4830, pembrolizumab, carboplatin, pemetrexed, lenvatinib, paclitaxel, cisplatin, mk-4830a KEAP1 BCL2 2
ociperlimab, tislelizumab, pemetrexed, paclitaxel, nab paclitaxel, carboplatin, cisplatin, etoposide, 5fluorouracil, oxaliplatin, capecitabine KEAP1 BCL2 2
olaparib KEAP1 PARP3 2
onc-392, pembrolizumab, docetaxel KEAP1 BCL2 2
paclitaxel KEAP1 BCL2 2
pembrolizumab, paclitaxel KEAP1 BCL2 2
pembrolizumab, paclitaxel, docetaxel, irinotecan KEAP1 BCL2 2
pembrolizumab/vibostolimab co-formulation, pembrolizumab, lenvatinib, 5-fluorouracil, cisplatin, paclitaxel, gemcitabine, carboplatin, docetaxel, bevacizumab, capecitabine, oxaliplatin KEAP1 BCL2 2
pralatrexate, docetaxel, fludeoxyglucose f 18, positron emission tomography KEAP1 BCL2 2
ramucirumab, paclitaxel KEAP1 BCL2 2
18f-fluoromisonidazole, cediranib maleate, laboratory biomarker analysis, olaparib, positron emission tomography KEAP1 PARP3 1
5-fluorouracil (5-fu), leucovorin, oxaliplatin, atezolizumab, cobimetinib, ramucirumab, paclitaxel, pegylated recombinant human hyaluronidase (pegph20), bl-8040, linagliptin, atezolizumab, cobimetinib, cisplatin, tiragolumab, 5-fluorouracil (5-fu) KEAP1 BCL2 1
5-fluorouracil, docetaxel, oxaliplatin KEAP1 BCL2 1
5-fluorouracil, leucovorin, oxaliplatin, docetaxel, carboplatin, paclitaxel, neoadjuvant radiation KEAP1 BCL2 1
5-fluoruracil, cisplatinum, docetaxel KEAP1 BCL2 1
5-fu, leucovorin, docetaxel, oxaliplatin (flot), trastuzumab, post-operative treatment trastuzumab mono therapy KEAP1 BCL2 1
afatinib, dasatinib, palbociclib, everolimus, olaparib KEAP1 PARP3 1
afatinib, dasatinib, palbociclib, everolimus, olaparib KEAP1 MAPK14 1
afatinib, docetaxel, radiation therapy KEAP1 BCL2 1
afuresertib, nab paclitaxel, docetaxel, sintilimab KEAP1 BCL2 1
agent-797, botensilimab, balstilimab, ramucirumab, paclitaxel KEAP1 BCL2 1
ak109, paclitaxel, paclitaxel, ak104 KEAP1 BCL2 1
aldesleukin, autologous tumor cell vaccine, filgrastim, sargramostim, therapeutic autologous lymphocytes, carmustine, cisplatin, cyclophosphamide, paclitaxel, autologous bone marrow transplantation, conventional surgery, peripheral blood stem cell transplantation KEAP1 BCL2 1
alpelisib, everolimus, exemestane KEAP1 PIK3CA 1
alvocidib, docetaxel KEAP1 BCL2 1
andecaliximab, gemcitabine, nab-paclitaxel, carboplatin, pemetrexed, leucovorin, oxaliplatin, 5-fu, bevacizumab, irinotecan, paclitaxel KEAP1 BCL2 1
anetumab ravtansine, bevacizumab, paclitaxel KEAP1 BCL2 1
ascorbic acid, paclitaxel protein-bound, cisplatin, gemcitabine KEAP1 EGLN1 1
atezolizumab, 5-fluorouracil, calciumfolinat, oxaliplatin, docetaxel KEAP1 BCL2 1
atezolizumab, biospecimen collection, capecitabine, computed tomography, docetaxel, echocardiography, fluorouracil, leucovorin calcium, lymphadenectomy, magnetic resonance imaging, oxaliplatin, positron emission tomography, surgical procedure KEAP1 BCL2 1
atezolizumab, tiragolumab, paclitaxel, cisplatin, atezolizumab matching placebo, tiragolumab matching placebo KEAP1 BCL2 1
avelumab, irinotecan, paclitaxel, best supportive care (bsc) KEAP1 BCL2 1
azd1775, olaparib KEAP1 PARP3 1
azd6244, dacarbazine, erlotinib, docetaxel, temsirolimus KEAP1 BCL2 1
bbi608, paclitaxel, placebo KEAP1 BCL2 1
bemarituzumab, paclitaxel, ramucirumab, bemarituzumab, irinotecan, bemarituzumab, trifluridine/tipiracil KEAP1 BCL2 1
bethanechol KEAP1 CHRM4 1
bethanechol, gemcitabine, nab-paclitaxel KEAP1 CHRM4 1
bevacizumab, cediranib, cediranib maleate, olaparib KEAP1 PARP3 1
bevacizumab, dasatinib, placebo KEAP1 MAPK14 1
bevacizumab, docetaxel, oxaliplatin KEAP1 BCL2 1
biological ni-1801, ni-1801 in combination with anti-pd1 (pembrolizumab), ni-1801 in combination with paclitaxel, paclitaxel KEAP1 BCL2 1
biopsy, biospecimen collection, computed tomography, copanlisib, magnetic resonance imaging KEAP1 PIK3CB 1
biopsy, biospecimen collection, computed tomography, copanlisib, magnetic resonance imaging KEAP1 PIK3CA 1
biopsy, biospecimen collection, computed tomography, magnetic resonance imaging, olaparib KEAP1 PARP3 1
biopsy, biospecimen collection, computed tomography, magnetic resonance imaging, olaparib, pembrolizumab KEAP1 PARP3 1
biopsy, biospecimen collection, copanlisib, radiologic examination KEAP1 PIK3CB 1
biopsy, biospecimen collection, copanlisib, radiologic examination KEAP1 PIK3CA 1
biospecimen collection, cholestyramine, computed tomography, diagnostic imaging, gemcitabine, leflunomide, magnetic resonance imaging KEAP1 DHODH 1
biospecimen collection, computed tomography, endoscopic ultrasound, esophagogastroduodenoscopy, fluorouracil, hypofractionated radiation therapy, leucovorin calcium, oxaliplatin, positron emission tomography, survey administration, docetaxel KEAP1 BCL2 1
biospecimen collection, computed tomography, magnetic resonance imaging, nivolumab, paclitaxel, questionnaire administration, ramucirumab KEAP1 BCL2 1
biospecimen collection, computed tomography, magnetic resonance imaging, olaparib, placebo administration KEAP1 PARP3 1
biospecimen collection, electronic health record review, fentanyl citrate, propofol, questionnaire administration, sevoflurane, surgical procedure KEAP1 SCN4A 1
biospecimen collection, lidocaine, resection KEAP1 SCN4A 1
bl-b01d1, irinotecan, paclitaxel, docetaxel KEAP1 BCL2 1
bnt327 dose level 1 (dl1), bnt327 dose level 2 (dl2), etoposide, carboplatin, paclitaxel, topotecan KEAP1 BCL2 1
bortezomib, carboplatin, paclitaxel KEAP1 BCL2 1
cadonilimab, ak117, oxaliplatin, tegafur-gimeracil-oteracil potassium, docetaxel, 5-fluorouracil KEAP1 BCL2 1
cadonilimab, pulocimab, paclitaxel, placebo KEAP1 BCL2 1
cadonilimab, radiotherapy, carboplatin, paclitaxel KEAP1 BCL2 1
camrelizumab, docetaxel, irinotecan KEAP1 BCL2 1
camrelizumab, irinotecan, paclitaxel, paclitaxel-albumin, docetaxel, anlotinib KEAP1 BCL2 1
camrelizumab, paclitaxel, cisplatin KEAP1 BCL2 1
camrelizumab, paclitaxel, cisplatin, radiotherapy KEAP1 BCL2 1
capecitabine, carboplatin, docetaxel, fluorouracil, hafnium oxide-containing nanoparticles nbtxr3, intensity-modulated radiation therapy, leucovorin, oxaliplatin, paclitaxel KEAP1 BCL2 1
capecitabine, cisplatin, docetaxel, epirubicin hydrochloride, gemcitabine hydrochloride KEAP1 BCL2 1
capecitabine, docetaxel, fluorouracil, leucovorin, oxaliplatin, radiation therapy, surgical procedure KEAP1 BCL2 1
capecitabine, docetaxel, fluorouracil, oxaliplatin, radiation therapy, therapeutic conventional surgery KEAP1 BCL2 1
capecitabine, medi4736 (durvalumab), trastuzumab, rucaparib, ramucirumab KEAP1 PARP3 1
carboplatin, 3 dimensional conformal radiation therapy, propranolol, intensity modulated radiation therapy, paclitaxel KEAP1 BCL2 1
carboplatin, cisplatin, docetaxel, etoposide, pembrolizumab KEAP1 BCL2 1
carboplatin, computed tomography, fluorouracil, laboratory biomarker analysis, leucovorin calcium, oxaliplatin, paclitaxel, pembrolizumab, positron emission tomography, radiation therapy, therapeutic conventional surgery KEAP1 BCL2 1
carboplatin, ganetespib, paclitaxel, radiation therapy KEAP1 BCL2 1
carboplatin, laboratory biomarker analysis, paclitaxel, quality-of-life assessment, radiation therapy, therapeutic conventional surgery, trastuzumab KEAP1 BCL2 1
carboplatin, laboratory biomarker analysis, paclitaxel, wild-type reovirus KEAP1 BCL2 1
carboplatin, paclitaxel, azd1775 KEAP1 BCL2 1
carboplatin, paclitaxel, vadimezan KEAP1 BCL2 1
carboxyamidotriazole, paclitaxel KEAP1 BCL2 1
catumaxomab, fluorouracil, leucovorin, oxaliplatin, docetaxel, fluorouracil, leucovorin, oxaliplatin, docetaxel KEAP1 BCL2 1
ce-mark approved laa closure devices, acetylsalicylic acid, clopidogrel, dabigatran, rivaroxaban, apixaban, edoxaban, phenprocoumon, warfarin KEAP1 MYC 1
ceralasertib, olaparib, durvalumab KEAP1 PARP3 1
cetuximab (erbitux), paclitaxel, cisplatin, radiation KEAP1 BCL2 1
cetuximab, cisplatin, paclitaxel, radiation therapy KEAP1 BCL2 1
cisplatin, docetaxel, floxuridine, fluorouracil, leucovorin calcium, conventional surgery KEAP1 BCL2 1
cisplatin, docetaxel, fluorouracil, radiation therapy KEAP1 BCL2 1
cisplatin, docetaxel, gemcitabine hydrochloride KEAP1 BCL2 1
cisplatin, docetaxel, gemcitabine hydrochloride, irinotecan hydrochloride KEAP1 BCL2 1
cisplatin, irinotecan hydrochloride, paclitaxel, conventional surgery, radiation therapy KEAP1 BCL2 1
cisplatin, oxaliplatin, fluorouracil (5-fu), capecitabine, paclitaxel, tislelizumab, placebo KEAP1 BCL2 1
cisplatin, paclitaxel, 5-fu KEAP1 BCL2 1
cisplatin, paclitaxel, adjuvant therapy, radiation therapy KEAP1 BCL2 1
cisplatin, paclitaxel, brachytherapy, radiation therapy KEAP1 BCL2 1
cisplatin, paclitaxel, surgical procedure KEAP1 BCL2 1
cisplatin, paclitaxel, topotecan hydrochloride KEAP1 BCL2 1
cobimetinib, olaparib, onvansertib, azenosertib, saruparib, tremelimumab KEAP1 PARP3 1
crenolanib, ramucirumab, paclitaxel KEAP1 BCL2 1
dalteparin, gemcitabine hydrochloride, diagnostic laboratory biomarker analysis KEAP1 SELP 1
dalteparin, gemcitabine hydrochloride, diagnostic laboratory biomarker analysis KEAP1 SERPINC1 1
dalteparin, radiation therapy KEAP1 SELP 1
dalteparin, radiation therapy KEAP1 SERPINC1 1
dasatinib, erlotinib hydrochloride, gemcitabine hydrochloride KEAP1 MAPK14 1
dasatinib, gemcitabine hydrochloride, laboratory biomarker analysis, mutation analysis, nucleic acid sequencing, immunohistochemistry staining method KEAP1 MAPK14 1
dasatinib, laboratory biomarker analysis, physiologic testing KEAP1 MAPK14 1
dasatinib, mfolfox6 KEAP1 MAPK14 1
dasatinib, pharmacological study KEAP1 MAPK14 1
dasatinib, temozolomide, placebo, radiation therapy KEAP1 MAPK14 1
dexamethasone, diphenhydramine, famotidine, mitomycin c, cisplatin, paclitaxel KEAP1 HRH2 1
dexamethasone, diphenhydramine, famotidine, mitomycin c, cisplatin, paclitaxel KEAP1 BCL2 1
disulfiram, copper, alkylating agents KEAP1 SERPINC1 1
docetaxel KEAP1 BCL2 1
docetaxel for injection (albumin-bound), sg001, cisplatin for injection, paclitaxel, simultaneous radiotherapy KEAP1 BCL2 1
docetaxel, 5-fluorouracil, oxaliplatin, folinic acid KEAP1 BCL2 1
docetaxel, cisplatin and 5-fluorouracil KEAP1 BCL2 1
docetaxel, cisplatin, capecitabine, radiation, capecitabine KEAP1 BCL2 1
docetaxel, cisplatin, fluorouracil, bevacizumab, leucovorin KEAP1 BCL2 1
docetaxel, cisplatin, radiation, surgery, vinorelbine, cisplatin KEAP1 BCL2 1
docetaxel, cisplatin, radiotherapy KEAP1 BCL2 1
docetaxel, fgfr inhibitor azd4547, laboratory biomarker analysis KEAP1 BCL2 1
docetaxel, floxuridine, leucovorin, oxaliplatin, microarray analysis, reverse transcriptase-polymerase chain reaction, conventional surgery KEAP1 BCL2 1
docetaxel, fluorouracil, oxaliplatin, pembrolizumab, radiation therapy KEAP1 BCL2 1
docetaxel, gemcitabine KEAP1 BCL2 1
docetaxel, gemcitabine hydrochloride KEAP1 BCL2 1
docetaxel, hyperfractionation, intensity-modulated radiation therapy, laboratory biomarker analysis, quality-of-life assessment KEAP1 BCL2 1
docetaxel, irinotecan hydrochloride KEAP1 BCL2 1
docetaxel, laboratory biomarker analysis, palbociclib KEAP1 BCL2 1
docetaxel, leucovorin, fluorouracil, cisplatin, docetaxel, cisplatin, fluorouracil, neulasta, or neupogen, docetaxel, leukvorin, flurouracil, cisplatin, trastuzumab KEAP1 BCL2 1
docetaxel, nedaplatin, chest radiation KEAP1 BCL2 1
docetaxel, oxaliplatin, capecitabine, trastuzumab KEAP1 BCL2 1
docetaxel, oxaliplatin, leucovorin, fluorouracil KEAP1 BCL2 1
docetaxel, oxaliplatin, radiotherapy KEAP1 BCL2 1
docetaxel, oxaliplatin, s-1 and durvalumab, durvalumab and tremelimumab KEAP1 BCL2 1
docetaxel, rna analysis, reverse transcriptase-polymerase chain reaction, circulating tumor cell analysis, laboratory biomarker analysis KEAP1 BCL2 1
docetaxel, steroid therapy, questionnaire administration, nausea and vomiting therapy, pain therapy, quality-of-life assessment, standard follow-up care, radiation therapy KEAP1 BCL2 1
durvalumab, carboplatin, paclitaxel, radiotherapy 23 x 1.8 gy KEAP1 BCL2 1
durvalumab, olaparib KEAP1 PARP3 1
durvalumab, olaparib, cediranib KEAP1 PARP3 1
durvalumab, tazemetostat KEAP1 EZH1 1
endoscopic variceal ligation, carvedilol KEAP1 ADRA2B 1
ep0057, olaparib KEAP1 PARP3 1
epacadostat, pembrolizumab, oxaliplatin, leucovorin, 5-fluorouracil, gemcitabine, nab-paclitaxel, carboplatin, paclitaxel, pemetrexed, cyclophosphamide, carboplatin, cisplatin, 5-fluorouracil, investigator's choice of platinum agent KEAP1 BCL2 1
epirubicin, cisplatin / oxaliplatin, 5 flourouracil/ capecitabine, (41.4 gy/23 fractions), paclitaxel, carboplatin, docetaxel, oxaliplatin, leucovorin, 5-fluorouracil KEAP1 BCL2 1
eras-007, encorafenib, cetuximab, palbociclib KEAP1 STK36 1
eras-007, encorafenib, cetuximab, palbociclib KEAP1 MAPK9 1
ethanol, enoxaparin KEAP1 CACNG1 1
ethanol, enoxaparin KEAP1 CHRNA9 1
ethanol, enoxaparin KEAP1 SERPINC1 1
etomidate, midazolam, meperidine KEAP1 ADRA2B 1
evorpacept (alx148), trastuzumab, ramucirumab, paclitaxel KEAP1 BCL2 1
external beam radiotherapy, bintrafusp alfa, paclitaxel, carboplatin KEAP1 BCL2 1
farletuzumab, placebo, carboplatin, paclitaxel, pemetrexed, cisplatin KEAP1 BCL2 1
filgrastim, amifostine trihydrate, cisplatin, etoposide, paclitaxel, topotecan hydrochloride, radiation therapy KEAP1 BCL2 1
filgrastim, carboplatin, cyclophosphamide, paclitaxel, topotecan hydrochloride, peripheral blood stem cell transplantation KEAP1 BCL2 1
filgrastim, carboplatin, etoposide, paclitaxel, topotecan hydrochloride, radiation therapy KEAP1 BCL2 1
filgrastim, carboplatin, paclitaxel, topotecan hydrochloride KEAP1 BCL2 1
filgrastim, docetaxel, gemcitabine hydrochloride KEAP1 BCL2 1
fluorouracil, irinotecan sucrosofate, laboratory biomarker analysis, leucovorin calcium, rucaparib KEAP1 PARP3 1
folfox regimen, docetaxel, fluorouracil, irinotecan hydrochloride, leucovorin calcium, oxaliplatin KEAP1 BCL2 1
folfox/ nal-iri, paclitaxel, carboplatin, proton radiation therapy KEAP1 BCL2 1
fosifloxuridine nafalbenamide, leucovorin, pembrolizumab, docetaxel KEAP1 BCL2 1
gb201, paclitaxel, gemcitabine, standard of care treatment options KEAP1 BCL2 1
Approval data manually curated from National Cancer Institute and Drugs@FDA. Clinical trials from ClinicalTrials.gov. Repositionable candidates from cansar.ai — these are potential drug-cancer reuse candidates, not evidence of efficacy.